AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Australian Clinical Labs Ltd

2.810

+0.0100.36%

Volume:739.00K

Turnover:2.07M

Market Cap:543.09M

PE:16.48

High:2.840

Open:2.820

Low:2.780

Close:2.800

52wk High:3.666

52wk Low:2.380

Shares:193.27M

Float Shares:187.68M

Volume Ratio:1.48

T/O Rate:0.39%

Dividend:0.13

Dividend Rate:4.45%

EPS(TTM):0.171

EPS(LYR):0.171

ROE:18.77%

ROA:7.28%

PB:3.17

PE(LYR):16.39

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

The 2025 AGM Season Shows Shareholder Scrutiny, Focus on Board Accountability, Says Jarden

MT Newswires Live

Optiscan Imaging, Australian Clinical Labs to Collaborate on Head, Neck Cancer Surgery Imaging Study

MT Newswires Live

We’re not in Kansas anymore

MOEA Takes Home 7 Awards at R&D100

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACL.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACL.AU\",,,,,undefined,":{"symbol":"ACL.AU","market":"AU","secType":"STK","nameCN":"Australian Clinical Labs Ltd","latestPrice":2.81,"timestamp":1766034720000,"preClose":2.8,"halted":0,"volume":738996,"delay":0,"nameEN":"Australian Clinical Labs Ltd","floatShares":187681218,"shares":193269940,"eps":0.1705,"marketStatus":"Not Yet Opened","change":0.01,"latestTime":"12-18 16:12:00 AEDT","open":2.82,"high":2.84,"low":2.78,"amount":2070442,"amplitude":0.021429,"askPrice":2.85,"askSize":3855,"bidPrice":2.75,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":0.1705,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766098800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.8,"dividendRate":0.044484,"openAndCloseTimeList":[[1766012400000,1766034000000]],"volumeRatio":1.475534,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACL.AU\",,,,,undefined,":{"symbol":"ACL.AU","floatShares":187681218,"roa":"7.28%","roe":"18.77%","lyrEps":0.171472,"volumeRatio":1.475534,"shares":193269940,"dividePrice":0.125,"high":2.84,"amplitude":0.021429,"preClose":2.8,"low":2.78,"week52Low":2.38,"pbRate":"3.17","psRate":"0.73","week52High":3.666,"institutionHeld":0,"latestPrice":2.81,"committee":0.676797,"eps":0.1705,"divideRate":0.044484,"volume":738996,"delay":0,"ttmEps":0.1705,"open":2.82,"prevYearClose":3.293,"prevWeekClose":2.82,"prevMonthClose":2.92,"prevQuarterClose":2.4,"fiveDayClose":2.82,"twentyDayClose":2.77,"sixtyDayClose":2.51,"dividendPayoutRate":0.7289819912288886,"dividendGrowthYears":1,"dividendGrowthRate":0.24999999999999994,"fiveYearAvgDividendRate":0.07489242701713679},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACL.AU\",params:#limit:5,,,undefined,":[{"date":"2025-09-01","symbol":"ACL.AU","amount":0.09,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-02","defaultRemindTime":1756684800000,"name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-02","currency":"AUD","dateTimestamp":1756648800000,"payDate":"2025-09-23"},{"date":"2025-08-26","symbol":"ACL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-03-27","symbol":"ACL.AU","amount":0.035,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-28","name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-16","payableDate":"2025-03-28","currency":"AUD","dateTimestamp":1742994000000,"payDate":"2025-04-16"},{"date":"2025-02-25","symbol":"ACL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740438000000,"name":null,"time":"","dateTimestamp":1740402000000,"actualEps":null},{"date":"2024-09-04","symbol":"ACL.AU","amount":0.09,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-05","defaultRemindTime":1725408000000,"name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-27","payableDate":"2024-09-05","currency":"AUD","dateTimestamp":1725372000000,"payDate":"2024-09-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2022-08-23","recordDate":"2022-08-24","paymentDate":"2022-09-15","value":0.41,"currency":"AUD"},{"executeDate":"2023-03-27","recordDate":"2023-03-28","paymentDate":"2023-04-26","value":0.07,"currency":"AUD"},{"executeDate":"2023-09-14","recordDate":"2023-09-15","paymentDate":"2023-10-03","value":0.07,"currency":"AUD"},{"executeDate":"2024-03-28","recordDate":"2024-04-02","paymentDate":"2024-04-26","value":0.03,"currency":"AUD"},{"executeDate":"2024-09-04","recordDate":"2024-09-05","paymentDate":"2024-09-27","value":0.09,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACL.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589865176","title":"The 2025 AGM Season Shows Shareholder Scrutiny, Focus on Board Accountability, Says Jarden","url":"https://stock-news.laohu8.com/highlight/detail?id=2589865176","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589865176?lang=en_us&edition=fundamental","pubTime":"2025-12-05 13:43","pubTimestamp":1764913425,"startTime":"0","endTime":"0","summary":"The 2025 annual general meeting season reflected elevated shareholder scrutiny, with investors remaining focused on board accountability, credible remuneration design, and governance track records, ac","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NWH.AU","BK7501","BK7124","IEL.AU","BK7135","BK7132","BK7055","BK7012","BK7031","BK4229","BK7508","WBC.AU","RWC.AU","REH.AU","JHX.AU","AGM","NAB.AU","ACL.AU","BK4195","BK7067","ANZ.AU","CSL.AU","BK7044","BK7511"],"gpt_icon":0},{"id":"2588096773","title":"Optiscan Imaging, Australian Clinical Labs to Collaborate on Head, Neck Cancer Surgery Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2588096773","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588096773?lang=en_us&edition=fundamental","pubTime":"2025-12-03 11:02","pubTimestamp":1764730937,"startTime":"0","endTime":"0","summary":"Optiscan Imaging (ASX:OIL) will conduct an imaging study in head and neck cancer surgery in collaboration with Australian Clinical Labs (ASX:ACL) using Optiscan's InVue precision surgery and InForm di","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","BK7007","OIL.AU","BK7124","XAO.AU","ACL.AU","XJO.AU"],"gpt_icon":0},{"id":"2586262069","title":"We’re not in Kansas anymore","url":"https://stock-news.laohu8.com/highlight/detail?id=2586262069","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586262069?lang=en_us&edition=fundamental","pubTime":"2025-11-27 04:15","pubTimestamp":1764188107,"startTime":"0","endTime":"0","summary":"One only needs to glance at a map of the US equity market to determine ‘We’re not in Kansas anymore’. The era of network economics and ever greater financialisation has wrought massive change on equity markets and increasingly on the real economy.Ever-growing government deficits and strong ongoing growth in household borrowing are funding a relatively buoyant profit environment, albeit one that is distributed increasingly unevenly. Disequilibrium is becoming the norm and the economic forces which tended to work against this are proving ineffective. While the reasons for this ongoing disequilibrium are debatable, a few seem important.Keen to display the power of monetary intervention in ‘smoothing’ economic cycles and preventing any downturn, central bankers everywhere have ensured additional credit and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/we-re-not-in-kansas-anymore","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/we-re-not-in-kansas-anymore","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7124","BK7508","BK7509","RHC.AU","XAO.AU","MQG.AU","ACL.AU","MPL.AU","BK7089","BK7501","BK7067","BK7046","HLS.AU","BK7135","BK7113","BK7511","XKO.AU","CBA.AU","SHL.AU","XJO.AU","CSL.AU"],"gpt_icon":0},{"id":"2585311385","title":"MOEA Takes Home 7 Awards at R&D100","url":"https://stock-news.laohu8.com/highlight/detail?id=2585311385","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585311385?lang=en_us&edition=fundamental","pubTime":"2025-11-21 16:30","pubTimestamp":1763713800,"startTime":"0","endTime":"0","summary":"18 Years, 100+ Awards: Taiwan's R&D Prowess Shines on Global StageTAIPEI, Nov. 21, 2025 /PRNewswire/ -- Taiwan's Ministry of Economic Affairs  announced today  that six technologies it funded have won seven awards at the 2025 R&D 100 Awards, often hailed as the \"Oscars of Innovation.\" The award-winning technologies include three from the Industrial Technology Research Institute , one from the Taiwan Textile Research Institute , one from the Metal Industries Research & Development Centre  , and one from the Institute for Information Industry . The winning technologies span key fields including AI, biomedical and healthcare, and green technology. Standing alongside world-renowned institutions, Taiwan's robust innovation and R&D capabilities are once again showcased on the international stage.","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2829586/Taiwan_s_Ministry_of_Economic_Affairs__MOEA__announced_today__21st__that_six_technologies_it_funded.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2829586/Taiwan_s_Ministry_of_Economic_Affairs__MOEA__announced_today__21st__that_six_technologies_it_funded.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/moea-takes-home-7-awards-at-rd100-302622999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","AI","LU2308191902.HKD","IE00B2PGVK34.USD","BK4195","BK4134","BK4585","BK4157","CFA.SI","IE00B3CCJ633.GBP","BK7124","BK4588","III","ACL.AU","BK4528","ITRI","BK4551","BK4543","BK4587","HBCP","IE00BGHQF417.EUR","BILS","LU2048586759.USD","BK4023"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACL.AU\",params:#limit:6,delay:true,,,undefined,":[]}}